Mergers: Commission waives the commitments made by Takeda to obtain clearance of its acquisition of Shire

pharma

(Credit: Unsplash)

This article is brought to you in association with the European Commission.


The European Commission has waived, under the EU Merger Regulation, the commitments made by Takeda to obtain clearance of its acquisition of Shire.

The Commission approved the acquisition of Shire by Takeda on 20 November 2018, subject to the divestment of a biologic drug under development by Shire to treat inflammatory bowel diseases (“IBD”), namely SHP 647.

IBD is a lifelong autoimmune disease that involve inflammation of the digestive tract. Biologic drugs are typically prescribed after the failure of conventional therapies, such as corticosteroids and immunosuppressants.

The Commission’s investigation

Following a number of circumstances that took place during the divestiture process, Takeda submitted a reasoned request to waive the commitments in their entirety.

Upon receipt of the request by Takeda to waive the commitments, the Commission has initiated a market investigation to determine whether a waiver is justified in light of the changed market conditions and developments.

The Commission’s investigation revealed that several permanent, significant and unforeseeable developments took place during the divestiture process, affecting both the evolution of the competitive landscape in IBD treatments and the development of Shire’s pipeline drug. In particular, during the divestiture process: (i) new promising drugs have emerged, which are expected to have a better efficacy and safety profile than the ones of Takeda’s and Shire’s drugs; (ii) some studies on SHP 647 yielded negative results; and (iii) the management of the divestment business experienced unforeseeable difficulties in recruiting patients for the clinical trials of SHP 647. These developments have negatively impacted the profile of SHP 647 and timeline with longer development duration, and severely impaired its prospects.

On this basis, the Commission concluded that the combination of the above developments amounted to exceptional circumstances so that the divestment of SHP 647 was no longer necessary to render Takeda’s acquisition of Shire compatible with the internal market.

As a result, the Commission has decided to waive the commitments submitted by Takeda in November 2018, in their entirety.

Companies involved

Takeda Pharmaceutical Company Limited, headquartered in Japan, is a global pharmaceutical company active in four main therapeutic areas: oncology, gastroenterology, neuroscience and vaccines.

Shire plc (now part of Takeda), headquartered in Ireland, is a global biopharmaceutical company, which specialises in developing treatments for rare diseases across a range of therapeutic areas including immunology, haematology, neuroscience, gastroenterology and genetic diseases.

Merger control rules and procedures

The transaction was notified to the Commission on 28 September 2018 and was approved, under the EU Merger Regulation by the Commission on 20 November 2018.

The Commission has the duty to assess mergers and acquisitions involving companies with a turnover above certain thresholds (see Article 1 of the Merger Regulation) and to prevent concentrations that would significantly impede effective competition in the EEA or any substantial part of it.

The vast majority of notified mergers do not pose competition problems and are cleared after a routine review. From the moment a transaction is notified, the Commission generally has a total of 25 working days to decide whether to grant approval (Phase I) or to start an in-depth investigation (Phase II). This deadline is extended to 35 working days in cases where remedies are submitted by the parties, such as in this case.

More information will be available on the Commission’s competition website, in the public case register under the case number M.8955.

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Migration has set EU’s political clock ticking; the stagnating economy cannot help it and Turkey doesn’t cooperate

South Asia can become an innovation hub. Here’s how

Why a global recession isn’t inevitable

What does artificial intelligence do in medicine?

The benefits of a cashless society

Japan must urgently address long-standing concerns over foreign bribery enforcement

Coronavirus: Commission proposes to activate fiscal framework’s general escape clause to respond to pandemic

A Valentine’s Special: giving back, a dialogue of love

If on a summer’s night: is UK businesses’ “new deal” the only key to the “best of all worlds”?

World Retail Congress Dubai 2016: Retail’s night of nights

Virus Coronavirus: No time to die

Chart of the day: This is what violence does to a nation’s GDP

Palestine refugees’ relief chief warns Security Council money to fund Gaza operations will run out in mid-June

Africa-Europe Alliance: Four new financial guarantees worth €216 million signed under the EU External Investment Plan

European Junior Enterprises to address the significant skills mismatch in the EU between school and employment

What happiness can teach us about how we measure human development

Celebrities are helping the UK’s schoolchildren learn during lockdown

Taking fast road to ‘e-mobility’ central to a sustainable future: COP24

US-China trade war is a ‘lose-lose’ situation for them and the world, warn UN economists

This digital currency could build a more sustainable global economy

UN relief chief urges Security Council to back aid delivery, more funding for millions of Syrians hit by harsh weather

EU to finance new investment projects with extra borrowing; French and Italian deficits to be tolerated

Could the fourth wave of globalization help to end epidemics?

EU adopts rebalancing measures in reaction to US steel and aluminium tariffs

UN chief welcomes start of Church-mediated national dialogue in Nicaragua

It’s time for global businesses to accept local responsibility

WHO working to save lives following powerful earthquake in Albania

Parliament demands ban on neo-fascist and neo-Nazi groups in the EU

We won’t win the online security war without people power

Grave concern over escalating humanitarian crisis, casualties, displacement across northwest Syria: UN

Banks can fight financial crime. But we can’t do it alone

China-EU Summit on 16-17 July 2018: “Work together to address common challenges”, by China’s Ambassador to the EU

Juncker Plan exceeds original €315 billion investment target

Rising inequality affecting more than two-thirds of the globe, but it’s not inevitable: new UN report

25 years on from genocide against the Tutsi, UN Chief warns of ‘dangerous trends of rising xenophobia, racism and intolerance’

How cities, not states, can solve the world’s biggest problems

Mergers: Commission prohibits proposed merger between Tata Steel and ThyssenKrupp

Microplastics have been found in Rocky Mountain rainwater

Mali: Two peacekeepers dead after dawn attack, several injured – UN Mission

Russia and the West to partition Ukraine?

RescEU: MEPs vote to upgrade EU civil protection capacity

Professional practices of primary health care for Brazilian health and gender inequality

Universities need strategic leadership. Here’s what it looks like

The health of the human being in coexistence with a transformative biosphere

Voices of Afghan women ‘must be heard at the table in the peace process and beyond’ UN deputy chief tells Security Council

Managing and resolving conflicts in a politically inclined group of team members

Telemedicine and the Brazilian reality

UN’s Grandi slams ‘toxic language of politics’ aimed at refugees, migrants

G20 to Germany: Abandon miser policies

German elections: Is Merkel losing ground or Shultz is winning?

EU paves the way for a stronger, more ambitious partnership with Africa

‘An unprecedented fiscal response’ – political and business leaders on managing the coronavirus crisis

Urgent action needed to address growing opioid crisis

I have a rare disease. This is my hope for the future of medicine

Bill Gates’ top 10 breakthrough technologies of 2019

Eurobarometer: protecting human rights tops citizens’ list of EU values

Global aid appeal targets more than 93 million most in need next year

Help prevent children ‘from becoming victims in the first place’, implores Guterres at campaign launch

Don’t let the virus quarantine your mind –Ways to strengthen “Mental” immunity

The developing countries keep the world going

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s